Clinical trial
Circulating HPV DNA in Cancers of the Anus and Uterine Cervix Treated With Definitive Radiation Therapy
NCT04857528 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating HPV DNA in Cancers of the Anus and Uterine Cervix Treated With Definitive Radiation Therapy
- Lead sponsor
- University of Chicago
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 6, 2020
- Completion date
- November 15, 2027
- Enrollment
- 20 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
anal cancer, cervical cancer, hpv-related anal squamous cell carcinoma, hpv-related carcinoma, hpv-related cervical carcinoma, uterine cervical cancer